Similarly, PI3K/AKT and mTOR pathways are important for majority of HNSCC tumors because of several driver mechanisms, and clinical trials with agents targeting these pathways in HNSCC are ongoing (24, 45). Here, MTOR is linked to head and neck squamous cell carcinoma.